A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

by Institute for Research in Biomedicine (IRB Barcelona)Credit: CC0 Public DomainScientists at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with the Centre for Geno

Updated on: May 20,2024 7

A machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

by Institute for Research in Biomedicine (IRB Barcelona)Credit: CC0 Public DomainScientists at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with the Centre for Geno

Updated on:May 20,2024 7

Rethinking existing method opens new doors for cancer diagnostics

by Osaka UniversityOperating principle of single-molecule quantum sequencing. Credit: Osaka UniversityAll diseases have a genetic component. Advances in understanding the genetic mechanisms behin

Updated on: April 07,2024 18

Rethinking existing method opens new doors for cancer diagnostics

by Osaka UniversityOperating principle of single-molecule quantum sequencing. Credit: Osaka UniversityAll diseases have a genetic component. Advances in understanding the genetic mechanisms behin

Updated on:April 07,2024 18

A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

by American Association for Cancer ResearchCredit: CC0 Public DomainA new liquid biopsy test could detect microsatellite instability (MSI) and tumor mutational burden (TMB), indicating that it co

Updated on: May 23,2024 8

A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

by American Association for Cancer ResearchCredit: CC0 Public DomainA new liquid biopsy test could detect microsatellite instability (MSI) and tumor mutational burden (TMB), indicating that it co

Updated on:May 23,2024 8

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

by Impact JournalsMechanisms of SCR resistance and characterization of the CD20 negative MCL cell lines 353. Credit: LeBlanc et al,Oncotarget(2022). DOI: 10.18632/oncotarget.28258A new res

Updated on: January 02,2024 9

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

by Impact JournalsMechanisms of SCR resistance and characterization of the CD20 negative MCL cell lines 353. Credit: LeBlanc et al,Oncotarget(2022). DOI: 10.18632/oncotarget.28258A new res

Updated on:January 02,2024 9

Researchers find link between obesity and blood cancer

by Jackie Maupin,Indiana University School of MedicineCredit: Unsplash/CC0 Public DomainIndiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential

Updated on: February 01,2024 16

Researchers find link between obesity and blood cancer

by Jackie Maupin,Indiana University School of MedicineCredit: Unsplash/CC0 Public DomainIndiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential

Updated on:February 01,2024 16

Tumor resistance is promoted by anti-cancer protein

by Champalimaud Centre for the UnknownCredit: CC0 Public DomainLack of oxygen, or hypoxia, is a biological stressor that occurs under various conditions such as wound healing and stroke. To rescue the

Updated on: April 09,2024 12

Tumor resistance is promoted by anti-cancer protein

by Champalimaud Centre for the UnknownCredit: CC0 Public DomainLack of oxygen, or hypoxia, is a biological stressor that occurs under various conditions such as wound healing and stroke. To rescue the

Updated on:April 09,2024 12

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on: November 11,2024 0

Research points to potential new treatment for aggressive prostate cancer subtype

byUniversity of MichiganProstate cancer cells. Credit: NIH Image GalleryWhen researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate c

Updated on:November 11,2024 0

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens

Updated on: May 09,2024 8

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens

Updated on:May 09,2024 8

Mailed self-sampling kits helped more women get screened for cervical cancer

by University of WashingtonHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress

Updated on: May 09,2024 7

Mailed self-sampling kits helped more women get screened for cervical cancer

by University of WashingtonHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress

Updated on:May 09,2024 7

Experts boost activity of potential therapeutic target in triple-negative breast cancer

by Diana Yates,University of Illinois at Urbana-ChampaignCredit: Unsplash/CC0 Public DomainLess than 20% of diagnosed breast cancers are designated "triple-negative," lacking three typ

Updated on: January 22,2024 17

Experts boost activity of potential therapeutic target in triple-negative breast cancer

by Diana Yates,University of Illinois at Urbana-ChampaignCredit: Unsplash/CC0 Public DomainLess than 20% of diagnosed breast cancers are designated "triple-negative," lacking three typ

Updated on:January 22,2024 17

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on: March 30,2024 15

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on:March 30,2024 15

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on: February 23,2024 14

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Updated on:February 23,2024 14